[1]
Demir, S. and Özkan, A. 2025. Vortioxetine modulates Nrf2/HO-1 signaling and antioxidant defense in a cuprizone-induced demyelination model. EXPERIMENTAL BIOMEDICAL RESEARCH. 8, 3 (Jul. 2025), 149–160. DOI:https://doi.org/10.30714/j-ebr.2025.245 .